Bruce Pollock

Last updated
  1. 1 2 "University of Toronto Psychiatry – Bruce Pollock".
  2. 1 2 "Google Scholar–Bruce G. Pollock".
  3. 1 2 "American College of Psychiatrists–Geriatric Award Nominations".
  4. 1 2 "William B. Abrams Award in Geriatric Clinical Pharmacology" (PDF).
  5. 1 2 "CAGP Outstanding Contributions in Geriatric Psychiatry".
  6. 1 2 "APA Council Reports" . American Journal of Psychiatry. 178 (10): 965–982. 2021. doi:10.1176/appi.ajp.2021.1781001. PMID   34592840.
  7. 1 2 "Distinguished Fellow of the Canadian Psychiatric Association". Canadian Psychiatric Association - Association des psychiatres du Canada.
  8. 1 2 "The Governor General of Canada–Dr. Bruce Godfrey Pollock".
  9. "The Canadian Journal of Psychiatry–Editorial Board".
  10. "International Psychogeriatrics–Editorial Board".
  11. "University of Toronto Pharmacology and Toxicology–Bruce G. Pollock".
  12. "CAMH–Dr. Bruce G. Pollock".
  13. "A cell-based assay and kits for assessing serum anticholinergic activity".
  14. Pollock, B. G.; Perel, J. M.; Kirshner, M.; Altieri, L. P.; Yeager, A. L.; Reynolds, C. F. (1991). "S-mephenytoin 4-hydroxylation in older Americans" . European Journal of Clinical Pharmacology. 40 (6): 609–611. doi:10.1007/BF00279979. PMID   1884743.
  15. Pollock, B. G.; Perel, J. M.; Altieri, L. P.; Kirshner, M.; Fasiczka, A. L.; Houck, P. R.; Reynolds Cf, 3rd (1992). "Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology". Psychopharmacology Bulletin. 28 (2): 163–168. PMID   1513919.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  16. Jin, Yuyan; Pollock, Bruce G.; Frank, Ellen; Cassano, Giovanni B.; Rucci, Paola; Müller, Daniel J.; Kennedy, James L.; Forgione, Rocco Nicola; Kirshner, Margaret; Kepple, Gail; Fagiolini, Andrea; Kupfer, David J.; Bies, Robert R. (2010). "Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure". The Journal of Clinical Pharmacology. 50 (1): 62–72. doi:10.1177/0091270009337946. PMC   3571021 . PMID   19841156.
  17. Bigos, Kristin L.; Pollock, Bruce G.; Aizenstein, Howard J.; Fisher, Patrick M.; Bies, Robert R.; Hariri, Ahmad R. (2008). "Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity". Neuropsychopharmacology. 33 (13): 3221–3225. doi:10.1038/npp.2008.52. PMC   2858321 . PMID   18463627.
  18. Pollock, B. (2000). "Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life Depression". Neuropsychopharmacology. 23 (5): 587–590. doi:10.1016/S0893-133X(00)00132-9. PMID   11027924.
  19. Lotrich, F. E.; Pollock, B. G.; Kirshner, M.; Ferrell, R. F.; Reynolds Iii, C. F. (2008). "Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients". Journal of Psychiatry & Neuroscience. 33 (2): 123–130. PMC   2265313 . PMID   18330458.
  20. Pollock, B. G.; Sweet, R. A.; Kirshner, M.; Reynolds, C. F. Iii (October 1996). "Bupropion Plasma Levels and CYP2D6 Phenotype" . Therapeutic Drug Monitoring. 18 (5): 581–585. doi:10.1097/00007691-199610000-00010. PMID   8885123.
  21. Murphy, G. (2001). "CYP2D6 Genotyping with Oligonucleotide Microarrays and Nortriptyline Concentrations in Geriatric Depression". Neuropsychopharmacology. 25 (5): 737–743. doi:10.1016/S0893-133X(01)00289-5. PMID   11682257.
  22. Pollock, Bruce G.; Wylie, Mary; Stack, Jacqueline A.; Sorisio, Denise A.; Thompson, Diane S.; Kirshner, Margaret A.; Folan, Maggie M.; Condifer, Kelly A. (1999). "Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women" . The Journal of Clinical Pharmacology. 39 (9): 936–940. doi:10.1177/00912709922008560. PMID   10471985.
  23. Pollock, Bruce G.; Laghrissi-Thode, Fouzia; Wagner, William R. (April 2000). "Evaluation of Platelet Activation in Depressed Patients With Ischemic Heart Disease After Paroxetine or Nortriptyline Treatment" . Journal of Clinical Psychopharmacology. 20 (2): 137–140. doi:10.1097/00004714-200004000-00004. PMID   10770450.
  24. Nebes, Robert D.; Pollock, Bruce G.; Houck, Patricia R.; Butters, Meryl A.; Mulsant, Benoit H.; Zmuda, Michelle D.; Reynolds, Charles F. (2003). "Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine" . Journal of Psychiatric Research. 37 (2): 99–108. doi:10.1016/S0022-3956(02)00085-7. PMID   12842163.
  25. Mamo, David C.; Pollock, Bruce G.; Mulsant, Benoit; Houck, Patricia R.; Bensasi, Salem; Miller, Mark C.; Redfern, Mark S.; Reynolds, Charles F. (2002). "Effects of Nortriptyline and Paroxetine on Postural Sway in Depressed Elderly Patients" . The American Journal of Geriatric Psychiatry. 10 (2): 199–205. doi:10.1097/00019442-200203000-00011. PMID   11925281.
  26. Fabian, Tanya J.; Amico, Janet A.; Kroboth, Patricia D.; Mulsant, Benoit H.; Corey, Sharon E.; Begley, Amy E.; Bensasi, Salem G.; Weber, Elizabeth; Dew, Mary Amanda; Reynolds Iii, Charles F.; Pollock, Bruce G. (2004). "Paroxetine-Induced Hyponatremia in Older Adults" . Archives of Internal Medicine. 164 (3): 327–332. doi:10.1001/archinte.164.3.327. PMID   14769630.
  27. Pollock, BG; Forsyth, CE; Bies, RR (2009). "The Critical Role of Clinical Pharmacology in Geriatric Psychopharmacology" . Clinical Pharmacology & Therapeutics. 85 (1): 89–93. doi:10.1038/clpt.2008.229. PMID   19037202.
  28. Jin, Yuyan; Pollock, Bruce G.; Coley, Kim; Miller, Del; Marder, Stephen R.; Florian, Jeff; Schneider, Lon; Lieberman, Jeffrey; Kirshner, Margaret; Bies, Robert R. (2010). "Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking". The Journal of Clinical Pharmacology. 50 (1): 73–80. doi:10.1177/0091270009343694. PMC   3648660 . PMID   19843655.
  29. Bigos, Kristin L.; Pollock, Bruce G.; Coley, Kim C.; Miller, Del D.; Marder, Stephen R.; Aravagiri, Manickam; Kirshner, Margaret A.; Schneider, Lon S.; Bies, Robert R. (2008). "Sex, Race, and Smoking Impact Olanzapine Exposure" . The Journal of Clinical Pharmacology. 48 (2): 157–165. doi:10.1177/0091270007310385. PMID   18199892.
  30. Bies, Robert R.; Mulsant, Benoit H.; Rosen, Jules; Huber, Kimberly A.; Wilson, Nicole L.; Kirshner, Margaret A.; Pollock, Bruce G. (2005). "Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances" . The American Journal of Geriatric Pharmacotherapy. 3 (2): 87–91. doi:10.1016/j.amjopharm.2005.07.002. PMID   16129385.
  31. Wessels, Alette M.; Pollock, Bruce G.; Anyama, Norbert G.; Schneider, Lon S.; Lieberman, Jeffrey A.; Marder, Stephen R.; Bies, Robert R. (2010). "Association of 9-Hydroxy Risperidone Concentrations With Risk of Switching or Discontinuation in the Clinical Antipsychotic Trial of Intervention Effectiveness-Alzheimer's Disease Trial" . Journal of Clinical Psychopharmacology. 30 (6): 683–687. doi:10.1097/JCP.0b013e3181fa05bb. PMID   21105282.
  32. Pollock, Bruce G.; Mulsant, Benoit H.; Rosen, Jules; Mazumdar, Sati; Blakesley, Richard E.; Houck, Patricia R.; Huber, Kimberly A. (2007). "A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia" . The American Journal of Geriatric Psychiatry. 15 (11): 942–952. doi:10.1097/JGP.0b013e3180cc1ff5. PMID   17846102.
  33. Porsteinsson, A. P.; Drye, L. T.; Pollock, B. G.; Devanand, D. P.; Frangakis, C.; Ismail, Z.; Marano, C.; Meinert, C. L.; Mintzer, J. E.; Munro, C. A.; Pelton, G.; Rabins, P. V.; Rosenberg, P. B.; Schneider, L. S.; Shade, D. M.; Weintraub, D.; Yesavage, J.; Lyketsos, C. G.; CitAD Research Group (2014). "Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial". JAMA. 311 (7): 682–691. doi:10.1001/jama.2014.93. PMC   4086818 . PMID   24549548.
  34. Ho, Thang; Pollock, Bruce G.; Mulsant, Benoit H.; Schantz, Oliver; Devanand, Devangere P.; Mintzer, Jacobo E.; Porsteinsson, Anton P.; Schneider, Lon S.; Weintraub, Daniel; Yesavage, Jerome; Drye, Lea T.; Munro, Cynthia A.; Shade, David M.; Lyketsos, Constantine; Bies, Robert (2016). "R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation". British Journal of Clinical Pharmacology. 82 (3): 784–792. doi:10.1111/bcp.12997. PMC   6445501 . PMID   27145364.
  35. Mulsant, B. H.; Pollock, B. G.; Kirshner, M.; Shen, C.; Dodge, H.; Ganguli, M. (2003). "Serum Anticholinergic Activity in a Community-Based Sample of Older Adults Relationship With Cognitive Performance". Archives of General Psychiatry. 60 (2): 198–203. doi:10.1001/archpsyc.60.2.198. PMID   12578438.
  36. Nebes, Robert D.; Pollock, Bruce G.; Perera, Subashan; Halligan, Edythe M.; Saxton, Judith A. (2012). "The Greater Sensitivity of Elderly APOE ε4 Carriers to Anticholinergic Medications is Independent of Cerebrovascular Disease Risk". The American Journal of Geriatric Pharmacotherapy. 10 (3): 185–192. doi:10.1016/j.amjopharm.2012.03.003. PMC   3367111 . PMID   22534472.
  37. Chew, Marci L.; Mulsant, Benoit H.; Pollock, Bruce G.; Lehman, Mark E.; Greenspan, Andrew; Mahmoud, Ramy A.; Kirshner, Margaret A.; Sorisio, Denise A.; Bies, Robert R.; Gharabawi, Georges (2008). "Anticholinergic Activity of 107 Medications Commonly Used by Older Adults" . Journal of the American Geriatrics Society. 56 (7): 1333–1341. doi:10.1111/j.1532-5415.2008.01737.x. PMID   18510583.
  38. Nobrega, José N.; Raymond, Roger J.; Pollock, Bruce G. (2017). "An improved, high-efficiency assay for assessing serum anticholinergic activity using cultured cells stably expressing M1 receptors" . Journal of Pharmacological and Toxicological Methods. 86: 28–33. doi:10.1016/j.vascn.2017.03.001. PMID   28274871.
Bruce Godfrey Pollock
Nationality Canadian American
Occupation(s)Academician and psychopharmacologist
Academic background
EducationBSc., Biological Sciences
MD
FRCPC., Psychiatry
PhD., Pharmacology
Alma mater University of Toronto
University of Pittsburgh